title: Modulation of Beta2 and Beta3 integrins in experimental colitis induced by iodoacetamide and enteropathogenic E. coli.
abstract: Integrins can modulate the infiltration of inflammatory cells and the secretion of various inflammatory mediators, essential players in the pathogenesis of colitis. This study explores the role of beta2 and beta3 integrin signaling and their possible role in experimental colitis. A total of 160 adult male Sprague-Dawly rats were divided into 4 equal groups: methylcellulose, bacteria, iodoacetamide and iodoacetamide plus bacteria. Clinical symptoms and signs of colitis were checked daily and colonic tissues were biopsied on days 3, 14, 28, and 56 post induction. Histological studies along with histochemical analysis and polymerase chain reaction of beta2, beta3 and alphavbeta3 were performed according to standard procedures. The symptoms and signs were consistent with previously reported data on active colitis. The highest expression of beta3 integrin was in the combined treatment mostly on platelets, endothelial and inflammatory cells. In the same group, the expression of alphavbeta3 integrin complex reached the highest score after 56 days in all colonic layers. Beta2 integrin expression showed a 3-4-fold increase in the combined treatment group at all time points and kept increasing till day 56. It was mostly expressed in the mucosa and submucosa. In addition, the expression of both &#945;v&#946;3 and &#945;ii&#946;3 integrins was also elevated 2- to 10-fold, respectively, in the same colitis groups throughout the duration of the experiment. In conclusion, the combined treatment of IA and Enteropathogenic E. coli led to a significant upregulation of all the tested integrins throughout the experimental duration. Such upregulation of integrins could have contributed to the increase and chronicity of inflammation.
authors.affiliation: Department of Anatomy, Cell Biology and Physiology, American University of Beirut, Lebanon.
authors.forename: I A
authors.initials: IA
authors.lastname: Hajj-Hussein
authors.forename: R
authors.initials: R
authors.lastname: Jurjus
authors.forename: J
authors.initials: J
authors.lastname: Saliba
authors.forename: S
authors.initials: S
authors.lastname: Ghanem
authors.forename: R
authors.initials: R
authors.lastname: Diab
authors.forename: T
authors.initials: T
authors.lastname: Bou Assi
authors.forename: H
authors.initials: H
authors.lastname: Daouk
authors.forename: A
authors.initials: A
authors.lastname: Leone
authors.forename: A
authors.initials: A
authors.lastname: Jurjus
mesh_terms: D000818:Animals; D018821:CD18 Antigens / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D003092:Colitis / Q000209:etiology / Q000378:metabolism*; D054308:Enteropathogenic Escherichia coli; D004927:Escherichia coli Infections / Q000150:complications; D007150:Immunohistochemistry; D039661:Integrin beta3 / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D007460:Iodoacetamide / Q000633:toxicity; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D015854:Up-Regulation
chemical_list: D018821:CD18 Antigens; D039661:Integrin beta3; D007460:Iodoacetamide